Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure

02 Aug Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure

Posted at 14:41h in Publications by

Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure

B Greenberg, J Butler, GM Felker, P Ponikowski, AA Voors, JM Pogoda, R Provost, J Guerrero, RJ Hajjar, KM Zsebo

Gene Ther. Author manuscript; available in PMC 2019 Jun 11.

Published in final edited form as: Gene Ther. 2016 Mar; 23(3): 313–319. Published online 2015 Dec 24. doi: 10.1038/gt.2015.109

PMCID: PMC6558655